Global BRIC Diabetes Care Devices Market Size study & Forecast, by Product (Blood Glucose Monitoring Devices), Distribution Channel (Hospital Pharmacy) and End Use and Regional Forecasts 2025-2035

The Global BRIC Diabetes Care Devices Market, valued at approximately USD 3.91 billion in 2024, is poised to surge at a robust CAGR of 8.60% between 2025 and 2035, reaching nearly USD 9.69 billion by the end of the forecast period. As diabetes prevalence climbs relentlessly across Brazil, Russia, India, and China, the demand for advanced, accurate, and user-friendly diabetes care technologies has intensified. These devices—most prominently blood glucose monitoring systems—have evolved from cumbersome, clinic-bound tools into compact, intuitive, and highly connected devices, empowering patients to take a more active role in their disease management. This transformation is being fueled not only by heightened disease awareness and government-led healthcare initiatives but also by a sweeping wave of digital health integration that enables seamless data tracking, telehealth consultations, and real-time patient–clinician collaboration.

The acceleration in diabetes incidence in BRIC nations has fundamentally altered the healthcare technology landscape. Factors such as sedentary lifestyles, rapid urbanization, and changing dietary patterns have collectively contributed to this surge, prompting urgent investments in medical devices that can provide continuous and precise health insights. According to the International Diabetes Federation, the BRIC region accounts for a significant share of the global diabetic population, with tens of millions at risk of developing type 2 diabetes in the coming decade. The market is further bolstered by favorable reimbursement frameworks in certain BRIC economies, increasing penetration of hospital pharmacies, and a growing emphasis on early diagnosis. However, despite the promising trajectory, challenges persist—particularly in rural and underserved areas where access to advanced devices remains limited and affordability continues to be a barrier to mass adoption.

Across the global market landscape, regional dynamics reveal a mosaic of growth opportunities and competitive intensity. China and India dominate the BRIC diabetes care device market, supported by vast patient pools, rising per capita healthcare spending, and accelerated adoption of digital health ecosystems. Russia is witnessing steady growth, driven by public healthcare investments and local manufacturing capabilities that cater to its expanding diabetic population. Brazil, on the other hand, is emerging as a lucrative market thanks to government-led programs aimed at subsidizing testing devices and enhancing access through hospital pharmacies. While BRIC remains the primary focus, global trends such as wearable glucose sensors, non-invasive monitoring technologies, and artificial intelligence–powered predictive analytics are increasingly influencing market offerings, creating pathways for domestic players to expand internationally.

Major market player included in this report are:
• Abbott Laboratories
• Roche Diabetes Care, Inc.
• Medtronic plc
• Becton, Dickinson and Company
• Ascensia Diabetes Care Holdings AG
• Johnson & Johnson (LifeScan, Inc.)
• Terumo Corporation
• Nipro Corporation
• Ypsomed Holding AG
• Dexcom, Inc.
• Sanofi S.A.
• Bayer AG
• Acon Laboratories, Inc.
• ARKRAY, Inc.
• Nova Biomedical

Global BRIC Diabetes Care Devices Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product:
• Blood Glucose Monitoring Devices

By Distribution Channel:
• Hospital Pharmacy

By End Use:
• Hospitals
• Homecare
• Others

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more